Reborna Biosciences

Japan
Fujisawa, Kanagawa, Japan, 251-8555

Company profile

Reborna Biosciences company profile

Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients suffering from rare genetic diseases including spinal muscular atrophy.

Business identity

Phone number
+81 466-32-1124
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2018-02-20

Headquarters

Postal code
251-8555
Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$7.6M
Last funding
Series Unknown / $5.3M / 2025-06-25
Last equity funding
Series Unknown / $5.3M
Investors
9
Lead investors
2
Founders
1
Articles
4

Founders and investors

Founders

Koji Fuji

Lead investors

Mitsubishi UFJ CapitalTakeda

Investors

Gogin CapitalMitsubishi UFJ CapitalNissay CapitalTakedaUntroD Capital